A detailed history of Moser Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Moser Wealth Advisors, LLC holds 13,743 shares of ABBV stock, worth $2.68 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
13,743
Previous 13,418 2.42%
Holding current value
$2.68 Million
Previous $2.44 Million 3.52%
% of portfolio
1.3%
Previous 1.38%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $50,306 - $58,747
325 Added 2.42%
13,743 $2.36 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $6,392 - $7,284
40 Added 0.3%
13,418 $2.44 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $13,072 - $14,722
-95 Reduced 0.71%
13,378 $2.07 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $49,691 - $61,837
-375 Reduced 2.71%
13,473 $1.82 Million
Q4 2022

Jan 12, 2023

SELL
$138.31 - $165.87 $8,990 - $10,781
-65 Reduced 0.47%
13,848 $2.24 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $275 - $349
2 Added 0.01%
13,913 $2.13 Million
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $13,428 - $16,991
125 Added 0.91%
13,911 $1.88 Million
Q3 2021

Oct 18, 2021

BUY
$106.4 - $120.78 $21,280 - $24,156
200 Added 1.47%
13,786 $1.49 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $15,781 - $17,581
150 Added 1.12%
13,586 $1.53 Million
Q1 2021

May 05, 2021

SELL
$102.3 - $112.62 $56,265 - $61,941
-550 Reduced 3.93%
13,436 $1.45 Million
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $10,309 - $12,099
-120 Reduced 0.85%
13,986 $1.23 Million
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $11,005 - $14,727
-150 Reduced 1.05%
14,106 $1.39 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $324,112 - $491,394
5,025 Added 54.44%
14,256 $1.09 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $665,832 - $833,097
9,231 New
9,231 $817,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Moser Wealth Advisors, LLC Portfolio

Follow Moser Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moser Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moser Wealth Advisors, LLC with notifications on news.